Platform Technology in Pediatrics with Rhaeos’ Anna Lisa Somera

https://is1-ssl.mzstatic.com/image/thumb/PodcastSource211/v4/33/d2/45/33d24523-af79-8f08-bbfc-fe77064493ac/1aa65594-2f7d-4ecb-ac99-ffa0e11326df.png/600x600bb.jpg

Impact1 Voices

Impact1 at Stanford Biodesign

9 episodes

4 days ago

Impact1 works to accelerate pediatric and maternal health technology to improve children’s lives from day one. In this podcast, co-hosts Janene Fuerch and Juliana Perl speak with leaders in healthcare innovation from around the globe to share insights on their challenges and successes in delivering new solutions. Impact1 is based at Stanford University’s Mussallem Center for Biodesign. Disclaimer of Endorsement: All references to specific products, companies, or services are for educational purposes only and do not constitute or imply an endorsement by Stanford University or Biodesign.

Medicine

Health & Fitness

RSS

All content for Impact1 Voices is the property of Impact1 at Stanford Biodesign and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42134477/42134477-1727807292622-93548f2d0d1ba.jpg

Platform Technology in Pediatrics with Rhaeos’ Anna Lisa Somera

Impact1 Voices

36 minutes 33 seconds

1 year ago

Platform Technology in Pediatrics with Rhaeos’ Anna Lisa Somera

Anna Lisa Somera is the CEO of Rhaeos, a company developing the FlowSense device to assess hydrocephalus shunt flow in pediatric and adult patients. In this episode, Anna Lisa discusses how her team chose to use their platform sensor technology to meet the needs of hydrocephalus patients and clinicians. She also addresses the benefits of family involvement in clinical trials, opportunities for non-dilutive funding, and resources outside of Silicon Valley.